Home/Filings/4/0001209191-22-046223
4//SEC Filing

Rickard Jason 4

Accession 0001209191-22-046223

CIK 0001446847other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 4:05 PM ET

Size

4.9 KB

Accession

0001209191-22-046223

Insider Transaction Report

Form 4
Period: 2022-08-15
Rickard Jason
SVP, Chief Operating Officer
Transactions
  • Sale

    Class A Common Stock

    2022-08-15$11.77/sh994$11,699375,736 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 4, 2018.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001808505

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:05 PM ET
Size
4.9 KB